QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Jonathan M. Pratt
CEOJonathan M. Pratt
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
8.76B
Market cap8.76B
Price-Earnings ratio
21.53
Price-Earnings ratio21.53
Dividend yield
0.83%
Dividend yield0.83%
Average volume
1.67M
Average volume1.67M
High today
$42.73
High today$42.73
Low today
$41.91
Low today$41.91
Open price
$42.12
Open price$42.12
Volume
1.09M
Volume1.09M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

As of today, QIAGEN(QGEN) shares are valued at $42.50. The company's market cap stands at 8.76B, with a P/E ratio of 21.53 and a dividend yield of 0.83%.

During the trading session on 2026-09-10, QIAGEN(QGEN) shares reached a daily high of $42.73 and a low of $41.91. At a current price of $42.50, the stock is +1.4% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 1.09M, compared to an average daily volume of 1.67M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

TipRanks 9h
Bank of America discloses 5.03% stake in QIAGEN via AFM filing

The latest update is out from Qiagen ( (QGEN) ). QIAGEN has disclosed a voting rights announcement after the Dutch financial regulator AFM notified the company...

TipRanks 18h
Qiagen initiated with a Neutral at UBS

UBS analyst Doug Schenkel initiated coverage of Qiagen (QGEN) with a Neutral rating and $47 price target The firm initiated and resumed 25 life science and diag...

TipRanks 1d
Qiagen grants performance-linked share units to CEO under MAR disclosure

Qiagen ( (QGEN) ) has provided an announcement. Qiagen has disclosed a managers’ transaction under EU Market Abuse Regulation, reporting performance share unit...

Analyst ratings

59%

of 22 ratings
Buy
40.9%
Hold
59.1%
Sell
0%

More QGEN News

Nasdaq 1d
Qiagen Shares Cross Below 200 DMA

In trading on Tuesday, shares of Qiagen NV (Symbol: QGEN) crossed below their 200 day moving average of $47.42, changing hands as low as $46.95 per share. Qiage...

Qiagen Shares Cross Below 200 DMA
TipRanks 5d
AFM discloses Goldman Sachs’ 2.91% stake in Qiagen

An announcement from Qiagen ( (QGEN) ) is now available. The Netherlands Authority for the Financial Markets has published a voting rights notification concern...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.